Trending...
- Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
- The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
- Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
SEOUL, South Korea, Nov. 20, 2023 ~ DeepBio, a Korean cancer diagnosis A.I. company, has been awarded the CES Innovation Award at the world's largest electronics exhibition, CES 2024. This marks the first time a Korean cancer diagnosis A.I. company has won this award.
The Consumer Technology Association (CTA) announced that DeepBio won the Innovation Award in the Digital Healthcare category for its diagnostic-aid software that helps detect meaningful findings among cancer patients.
DeepBio leverages its expertise in deep learning and cancer pathology to provide state-of-the-art in vitro diagnostic software (IVDs, SaMDs) that analyzes various cancers' cancerous areas and severity to help medical professionals make more informed decisions. DeepDx®-Prostate has a high precision of 99% sensitivity and 97% specificity.
More on nvtip.com
Kim Sun-woo, CEO of DeepBio, said: "We have proven our technical excellence both internally and externally, winning the silver medal at the Edison Awards in the United States and first place in 2019 at the Chameleon Challenge." He added: "We will strive to improve the cancer diagnosis environment and provide cutting-edge cancer diagnosis A.I. solutions to medical professionals through generous investment in technology to overcome the biggest challenge of humanity, cancer."
CES 2024 will be held at Las Vegas Convention Center from January 9th to 12th and DeepBio's award can be searched on CES Innovation Awards website.
The Consumer Technology Association (CTA) announced that DeepBio won the Innovation Award in the Digital Healthcare category for its diagnostic-aid software that helps detect meaningful findings among cancer patients.
DeepBio leverages its expertise in deep learning and cancer pathology to provide state-of-the-art in vitro diagnostic software (IVDs, SaMDs) that analyzes various cancers' cancerous areas and severity to help medical professionals make more informed decisions. DeepDx®-Prostate has a high precision of 99% sensitivity and 97% specificity.
More on nvtip.com
- Dr. Aubrey de Grey Brings Cutting-Edge Science to RAADfest 2025: LEV Foundation Partners with Coalition for Radical Life Extension
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
- Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild
Kim Sun-woo, CEO of DeepBio, said: "We have proven our technical excellence both internally and externally, winning the silver medal at the Edison Awards in the United States and first place in 2019 at the Chameleon Challenge." He added: "We will strive to improve the cancer diagnosis environment and provide cutting-edge cancer diagnosis A.I. solutions to medical professionals through generous investment in technology to overcome the biggest challenge of humanity, cancer."
CES 2024 will be held at Las Vegas Convention Center from January 9th to 12th and DeepBio's award can be searched on CES Innovation Awards website.
Filed Under: Business
0 Comments
Latest on nvtip.com
- Drone Light Shows Emerge as the New Standard in Live Event Entertainment
- Lore Link is Here to Help Organize Your Game
- Chappaqua's Annual Townwide Summer Sale – Unbeatable Savings at Your Favorite Local Boutiques!
- Inside the Mind of an Investor: What They Look for in a Business Plan
- Skyline Partners with ZenSpace to Offer Private Meeting Pods for Trade Show Exhibitors
- AI Innovation Dual-Strategy Business Model Focused on Real Estate Development for Strategic Expansion: OFA Group, (N A S D A Q: OFAL)
- Construcción del Corredor Norte–Sur (NSC) de Singapur
- New Report: Slip and Fall Accidents Rank as the Leading Cause of Construction Site Fatalities
- Get Your Cowboy Boots On! Causeway Country BBQ Music Festival Kicks Off September 12–14 in Ft. Pierce
- Retired Hobbyist Launches Bold Weekly Album Project Using AI Songwriting Tools
- DimHum Launches Revolutionary CrowdShipping Service
- Eolian Signs New Information Exchange Agreement with the U.S. Department of Defense for Technology Innovation
- Infinite Health Introduces Cutting-Edge Regenerative Medicine for Wound Care with Trip Goolsby, MD
- Top Dentist Concord CA, Smile Makers Dental Care, Celebrates 500 5-Star Reviews
- Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
- Michael Reafsnyder opens solo exhibition at Scott Richards Contemporary Art in San Francisco
- Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
- $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
- $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
- Pacsun Joins UFC International Fight Week with Exclusive Collection and First-Ever UFC X Activation